C. Andrew Kistler, MD, PharmD

Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.

All articles by C. Andrew Kistler, MD, PharmD

Obesity

IBD and Obesity: Is there a Connection?

C. Andrew Kistler, MD, PharmD

September 24, 2021

One key factor that has developed increasing research interest is the role of a patient’s BMI, specifically those with obesity (BMI > 30 kg/m2), in the development of IBD.

Bone Metabolism

IBD and Osteoporosis: Key Takeaways and New Data

C. Andrew Kistler, MD, PharmD

August 20, 2021

Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.

Woman with stomach pain sitting on bench

General Endocrinology

Low FODMAP Diet and IBD: A Potential Option?

C. Andrew Kistler, MD, PharmD

June 11, 2021

Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.